🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The proposed randomized clinical trial will investigate a novel pharmacothe...
Status
Completed
Location
Johns Hopkins Hospital
Start Date
2010-12
Trial ID
NCT01254877
Treatments Being Tested
The purpose of this study is to determine whether improvement in P50 (a pha...
Status
Terminated
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02614586
Treatments Being Tested
Opioid medications are commonly used for pain relief. When given over time,...
Status
Completed
Location
Stanford University
Start Date
2011-04
Trial ID
NCT01549652
Treatments Being Tested
The purpose of this study was to determine the appropriate dosing regimen o...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-13
Trial ID
NCT01697579
Treatments Being Tested
This a Phase III trial designed to determine if IV casopitant plus dexameth...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-03-10
Trial ID
NCT00601172
Treatments Being Tested
The aim of this study is to evaluate the overall effectiveness of Ondansetr...
Status
Completed
Location
Monash Alfred Psychiatry Research Centre (MAPrc)
Start Date
2010-07
Trial ID
NCT01121042
Treatments Being Tested
This study will compare the safety and efficacy of a three-day oral aprepit...
Status
Completed
Location
Multiple Locations
Start Date
2011-09-13
Trial ID
NCT01362530
The purpose is to evaluate the effectiveness and safety of fosaprepitant pl...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2022-08-01
Trial ID
NCT04508400
Treatments Being Tested
TOPHAT (Trial of Ondansetron as a Parkinson's HAllucinations Treatment) is ...
Status
Unknown
Location
Grampian
Start Date
2021-10-01
Trial ID
NCT04167813
Treatments Being Tested
Amisulpride is a potent antagonist of dopamine D2 and D3 receptors, both im...
Status
Recruiting
Location
Hospital da Mulher
Start Date
2025-04-10
Trial ID
NCT06887621